CytoMed Therapeutics Limited Adjustments For Decrease Increase In Other Operating Receivables
CytoMed Therapeutics Limited (GDTC) reported Adjustments For Decrease Increase In Other Operating Receivables of -SGD 5.26 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-22.
Discontinued › Notes
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables · last filed 2024-04-22
SGD
| Period end | Adjustments For Decrease Increase In Other Operating Receivables 12 month |
|---|---|
| 2023-12-31 | -5.26K SGD 20-F · filed 2024-04-22 |
| 2022-12-31 | -145.17K SGD 20-F · filed 2024-04-22 |
| 2021-12-31 | -433.12K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | -162.05K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Adjustments For Decrease Increase In Other Operating Receivables 12 month |
|---|---|
| 2023-12-31 | -$3.99K 20-F · filed 2024-04-22 |
| 2022-12-31 | -$108.30K 20-F · filed 2023-05-01 |